GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANWA) » Definitions » Inventories, Other

Immuron (FRA:ANWA) Inventories, Other : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Immuron Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Immuron's other inventories for the quarter that ended in Dec. 2023 was €0.00 Mil.

Immuron's quarterly other inventories stayed the same from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).

Immuron's annual other inventories increased from Jun. 2021 (€0.00 Mil) to Jun. 2022 (€0.00 Mil) but then declined from Jun. 2022 (€0.00 Mil) to Jun. 2023 (€0.00 Mil).

Immuron Inventories, Other Historical Data

The historical data trend for Immuron's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Inventories, Other Chart

Immuron Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only - - - - -

Immuron Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 - - - -

Immuron Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Immuron (FRA:ANWA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANWA) » Definitions » Inventories, Other
Comparable Companies
ASX:NOX ASX:ACR ASX:CHM ASX:1AI ASX:ATX ASX:ATH ASX:PAB ASX:RAD ASX:BTC ASX:1AD OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
IMRN:USA IMC:Australia
Address
Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130
Website
https://www.immuron.com.au
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Immuron (FRA:ANWA) Headlines

No Headlines